BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szallasi A, Cruz F, Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol Med 2006;12:545-54. [PMID: 16996800 DOI: 10.1016/j.molmed.2006.09.001] [Cited by in Crossref: 120] [Cited by in F6Publishing: 122] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ekstrand Y, Ternesten-Hasséus E, Arvidsson M, Löfdahl K, Palmqvist M, Millqvist E. Sensitivity to environmental irritants and capsaicin cough reaction in patients with a positive methacholine provocation test before and after treatment with inhaled corticosteroids. J Asthma 2011;48:482-9. [PMID: 21486197 DOI: 10.3109/02770903.2011.570405] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
2 Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24:142-54. [PMID: 18209521 DOI: 10.1097/AJP.0b013e318158ed9e] [Cited by in Crossref: 173] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
3 Ge S, Khachemoune A. Neuroanatomy of the Cutaneous Nervous System Regarding Wound Healing. Int J Low Extrem Wounds 2021;:15347346211054598. [PMID: 34779294 DOI: 10.1177/15347346211054598] [Reference Citation Analysis]
4 Kizawa K, Kitahara T, Horii A, Maekawa C, Kuramasu T, Kawashima T, Nishiike S, Doi K, Inohara H. Behavioral assessment and identification of a molecular marker in a salicylate-induced tinnitus in rats. Neuroscience 2010;165:1323-32. [DOI: 10.1016/j.neuroscience.2009.11.048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
5 Lim JO, Jin MK, Ryu H, Kang DW, Lee J, Pearce LV, Tran R, Toth A, Blumberg PM. Conformationally constrained analogues of N'-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists. Eur J Med Chem 2009;44:322-31. [PMID: 18406014 DOI: 10.1016/j.ejmech.2008.02.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Charrua A, Avelino A, Cruz F. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Handb Exp Pharmacol 2011;:345-74. [PMID: 21290235 DOI: 10.1007/978-3-642-16499-6_17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Aoki KR. Future aspects of botulinum neurotoxins. J Neural Transm (Vienna) 2008;115:567-73. [PMID: 17557128 DOI: 10.1007/s00702-007-0758-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
8 Liu L, Gu L, Chen M, Zheng Y, Xiong X, Zhu S. Novel Targets for Stroke Therapy: Special Focus on TRPC Channels and TRPC6. Front Aging Neurosci 2020;12:70. [PMID: 32256338 DOI: 10.3389/fnagi.2020.00070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Schmidt RG, Bayburt EK, Latshaw SP, Koenig JR, Daanen JF, Mcdonald HA, Bianchi BR, Zhong C, Joshi S, Honore P, Marsh KC, Lee C, Faltynek CR, Gomtsyan A. Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters 2011;21:1338-41. [DOI: 10.1016/j.bmcl.2011.01.056] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
10 Chang M, Park S, Kim J, Jang M, Park JH, Park JE, Park H, Suh Y, Jeong YS, Park Y, Kim H. Silicon switch approach in TRPV1 antagonist MK-056 and its analogues. Bioorganic & Medicinal Chemistry 2010;18:111-6. [DOI: 10.1016/j.bmc.2009.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Schnizler K, Shutov LP, Van Kanegan MJ, Merrill MA, Nichols B, McKnight GS, Strack S, Hell JW, Usachev YM. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J Neurosci 2008;28:4904-17. [PMID: 18463244 DOI: 10.1523/JNEUROSCI.0233-08.2008] [Cited by in Crossref: 109] [Cited by in F6Publishing: 75] [Article Influence: 7.8] [Reference Citation Analysis]
12 Shimizu T, Toriumi H, Sato H, Shibata M, Nagata E, Gotoh K, Suzuki N. Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat. Brain Research 2007;1173:84-91. [DOI: 10.1016/j.brainres.2007.07.068] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
13 Pini LA. Future drugs for migraine. Intern Emerg Med 2009;4:361-2. [PMID: 19707844 DOI: 10.1007/s11739-009-0299-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Farinelli I, De Filippis S, Coloprisco G, Missori S, Martelletti P. Future drugs for migraine. Intern Emerg Med 2009;4:367-73. [DOI: 10.1007/s11739-009-0273-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
15 Chen Y, Geis C, Sommer C. Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci 2008;28:5836-45. [PMID: 18509045 DOI: 10.1523/JNEUROSCI.4170-07.2008] [Cited by in Crossref: 103] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
16 Bao Y, Gao Y, Yang L, Kong X, Yu J, Hou W, Hua B. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence. Channels (Austin) 2015;9:235-43. [PMID: 26176938 DOI: 10.1080/19336950.2015.1069450] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
17 Gutierrez S, Alvarado-Vázquez PA, Eisenach JC, Romero-Sandoval EA, Boada MD. Tachykinins modulate nociceptive responsiveness and sensitization: In vivo electrical characterization of primary sensory neurons in tachykinin knockout (Tac1 KO) mice. Mol Pain 2019;15:1744806919845750. [PMID: 31012376 DOI: 10.1177/1744806919845750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Vasudevan A, Kort ME. Chapter 6 Advances in Transient Receptor Potential Modulators. Annual Reports in Medicinal Chemistry Volume 42. Elsevier; 2007. pp. 81-91. [DOI: 10.1016/s0065-7743(07)42006-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Rohacs T, Thyagarajan B, Lukacs V. Phospholipase C mediated modulation of TRPV1 channels. Mol Neurobiol 2008;37:153-63. [PMID: 18528787 DOI: 10.1007/s12035-008-8027-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
20 Ortíz-Rentería M, Juárez-Contreras R, González-Ramírez R, Islas LD, Sierra-Ramírez F, Llorente I, Simon SA, Hiriart M, Rosenbaum T, Morales-Lázaro SL. TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. Proc Natl Acad Sci U S A 2018;115:E1657-66. [PMID: 29378958 DOI: 10.1073/pnas.1715972115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
21 Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008;57:746-59. [PMID: 18341994 DOI: 10.1016/j.neuron.2007.12.027] [Cited by in Crossref: 266] [Cited by in F6Publishing: 272] [Article Influence: 19.0] [Reference Citation Analysis]
22 Okuhara DY, Hsia AY, Xie M. Transient receptor potential channels as drug targets. Expert Opinion on Therapeutic Targets 2007;11:391-401. [DOI: 10.1517/14728222.11.3.391] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
23 Docherty RJ, Farmer CE. The pharmacology of voltage-gated sodium channels in sensory neurones. Handb Exp Pharmacol 2009;:519-61. [PMID: 19655117 DOI: 10.1007/978-3-540-79090-7_15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
24 Gharat L, Szallasi A. Medicinal chemistry of the vanilloid (Capsaicin) TRPV1 receptor: current knowledge and future perspectives. Drug Dev Res 2007;68:477-97. [DOI: 10.1002/ddr.20218] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
25 Fernandes ES, Russell FA, Spina D, McDougall JJ, Graepel R, Gentry C, Staniland AA, Mountford DM, Keeble JE, Malcangio M, Bevan S, Brain SD. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis. Arthritis Rheum 2011;63:819-29. [PMID: 21360511 DOI: 10.1002/art.30150] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 12.9] [Reference Citation Analysis]
26 Mohammadi-Farani A, Sahebgharani M, Sepehrizadeh Z, Jaberi E, Ghazi-Khansari M. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray. Brain Res 2010;1328:49-56. [PMID: 20211611 DOI: 10.1016/j.brainres.2010.02.077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
27 Bao Y, Gao Y, Yang L, Kong X, Zheng H, Hou W, Hua B. New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review. Channels (Austin) 2015;9:5-13. [PMID: 25664811 DOI: 10.4161/19336950.2014.995001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Yin Y, Lee SY. Current View of Ligand and Lipid Recognition by the Menthol Receptor TRPM8. Trends Biochem Sci 2020;45:806-19. [PMID: 32532587 DOI: 10.1016/j.tibs.2020.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Ryu H, Seo S, Kim MS, Kim MY, Kim HS, Ann J, Tran PT, Hoang VH, Byun J, Cui M, Son K, Sharma PK, Choi S, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Koegel BY, Christoph T, Frormann S, Lee J. 2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists. Bioorg Med Chem Lett 2014;24:4044-7. [PMID: 25011915 DOI: 10.1016/j.bmcl.2014.05.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
30 Johansson EL, Ternesten-Hasséus E, Millqvist E. Down-regulation of cough sensitivity after eucapnic dry air provocation in chronic idiopathic cough. Pulm Pharmacol Ther 2009;22:543-7. [PMID: 19646543 DOI: 10.1016/j.pupt.2009.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Ma W, Quirion R. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 2007;11:307-20. [PMID: 17298290 DOI: 10.1517/14728222.11.3.307] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 5.7] [Reference Citation Analysis]
32 Jakubiec M, Abram M, Zagaja M, Andres-Mach M, Szewczyk A, Latacz G, Szulczyk B, Socała K, Nieoczym D, Wlaź P, Metcalf CS, Wilcox K, Kamiński RM, Kamiński K. New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants. Cells 2022;11:1862. [PMID: 35740990 DOI: 10.3390/cells11121862] [Reference Citation Analysis]
33 Kim MS, Ryu H, Kang DW, Cho SH, Seo S, Park YS, Kim MY, Kwak EJ, Kim YS, Bhondwe RS. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region. J Med Chem. 2012;55:8392-8408. [PMID: 22957803 DOI: 10.1021/jm300780p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
34 Cui M, Gosu V, Basith S, Hong S, Choi S. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor. Ion channels as therapeutic targets, part B. Elsevier; 2016. pp. 81-125. [DOI: 10.1016/bs.apcsb.2015.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
35 Szabó A, Czirják L, Sándor Z, Helyes Z, László T, Elekes K, Czömpöly T, Starr A, Brain S, Szolcsányi J, Pintér E. Investigation of sensory neurogenic components in a bleomycin-induced scleroderma model using transient receptor potential vanilloid 1 receptor- and calcitonin gene-related peptide-knockout mice. Arthritis Rheum 2008;58:292-301. [PMID: 18163477 DOI: 10.1002/art.23168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
36 Planells-Cases R, Valente P, Ferrer-Montiel A, Qin F, Szallasi A. Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. Adv Exp Med Biol 2011;704:491-515. [PMID: 21290313 DOI: 10.1007/978-94-007-0265-3_27] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
37 Susankova K, Ettrich R, Vyklicky L, Teisinger J, Vlachova V. Contribution of the putative inner-pore region to the gating of the transient receptor potential vanilloid subtype 1 channel (TRPV1). J Neurosci 2007;27:7578-85. [PMID: 17626219 DOI: 10.1523/JNEUROSCI.1956-07.2007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
38 Feng Q. Temperature sensing by thermal TRP channels: thermodynamic basis and molecular insights. Curr Top Membr 2014;74:19-50. [PMID: 25366232 DOI: 10.1016/B978-0-12-800181-3.00002-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
39 Xu H, Tian W, Fu Y, Oyama TT, Anderson S, Cohen DM. Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. Am J Physiol Renal Physiol. 2007;293:F1865-F1876. [PMID: 17913835 DOI: 10.1152/ajprenal.00347.2007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
40 Mandadi S, Roufogalis BD. ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1. Curr Neuropharmacol. 2008;6:21-38. [PMID: 19305786 DOI: 10.2174/157015908783769680] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
41 Brain SD. TRPV1 and TRPA1 channels in inflammatory pain: elucidating mechanisms. Ann N Y Acad Sci 2011;1245:36-7. [PMID: 22211974 DOI: 10.1111/j.1749-6632.2011.06326.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
42 Barnes PJ. The problem of cough and development of novel antitussives. Pulmonary Pharmacology & Therapeutics 2007;20:416-22. [DOI: 10.1016/j.pupt.2006.11.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
43 Khairatkar-joshi N, Szallasi A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends in Molecular Medicine 2009;15:14-22. [DOI: 10.1016/j.molmed.2008.11.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 6.8] [Reference Citation Analysis]
44 Sharma G, Chopra K, Puri S, Bishnoi M, Rishi P, Kaur IP. Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats. J Drug Target 2018;26:135-49. [PMID: 28670930 DOI: 10.1080/1061186X.2017.1350857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
45 Ha TH, Ryu H, Kim SE, Kim HS, Ann J, Tran PT, Hoang VH, Son K, Cui M, Choi S, Blumberg PM, Frank R, Bahrenberg G, Schiene K, Christoph T, Frormann S, Lee J. TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides. Bioorg Med Chem 2013;21:6657-64. [PMID: 24035514 DOI: 10.1016/j.bmc.2013.08.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
46 Romanovsky AA, Almeida MC, Garami A, Steiner AA, Norman MH, Morrison SF, Nakamura K, Burmeister JJ, Nucci TB. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 2009;61:228-61. [PMID: 19749171 DOI: 10.1124/pr.109.001263] [Cited by in Crossref: 162] [Cited by in F6Publishing: 158] [Article Influence: 12.5] [Reference Citation Analysis]
47 Gomtsyan A, Bayburt EK, Schmidt RG, Surowy CS, Honore P, Marsh KC, Hannick SM, Mcdonald HA, Wetter JM, Sullivan JP, Jarvis MF, Faltynek CR, Lee C. Identification of ( R )-1-(5- tert -Butyl-2,3-dihydro-1 H -inden-1-yl)-3-(1 H -indazol-4-yl)urea (ABT-102) as a Potent TRPV1 Antagonist for Pain Management. J Med Chem 2008;51:392-5. [DOI: 10.1021/jm701007g] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
48 olesen SS, olesen AE, gravesen F, poulsen JL, funch-jensen P, gregersen H, drewes AM. An endoscopic method for thermal and chemical stimulation of the human oesophagus. Neurogastroenterology & Motility 2009;21:1250-e116. [DOI: 10.1111/j.1365-2982.2009.01362.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
49 Bhondwe RS, Kang DW, Kim MS, Kim HS, Park SG, Son K, Choi S, Kuhs KA, Pavlyukovets VA, Pearce LV, Blumberg PM, Lee J. Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. Bioorg Med Chem Lett 2012;22:3656-60. [PMID: 22546668 DOI: 10.1016/j.bmcl.2012.04.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Hwang S, Jo Y, Cohen CF, Kim Y, Berta T, Park C. Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development. IJMS 2022;23:5772. [DOI: 10.3390/ijms23105772] [Reference Citation Analysis]
51 Kim YS, Kil MJ, Kang SU, Ryu H, Kim MS, Cho Y, Bhondwe RS, Thorat SA, Sun W, Liu K, Lee JH, Choi S, Pearce LV, Pavlyukovets VA, Morgan MA, Tran R, Lazar J, Blumberg PM, Lee J. N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region. Bioorg Med Chem 2012;20:215-24. [PMID: 22169633 DOI: 10.1016/j.bmc.2011.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
52 Zakaria ZA, Roosli RAJ, Marmaya NH, Omar MH, Basir R, Somchit MN. Methanol Extract of Dicranopteris linearis Leaves Attenuate Pain via the Modulation of Opioid/NO-Mediated Pathway. Biomolecules 2020;10:E280. [PMID: 32059475 DOI: 10.3390/biom10020280] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Chizh BA, Sang CN. Use of sensory methods for detecting target engagement in clinical trials of new analgesics. Neurotherapeutics 2009;6:749-54. [PMID: 19789077 DOI: 10.1016/j.nurt.2009.08.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
54 Buckley CL, Stokes AJ. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy. Channels (Austin) 2011;5:367-74. [PMID: 21814047 DOI: 10.4161/chan.5.4.17083] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
55 Cruz CD. Neurotrophins in bladder function: what do we know and where do we go from here? Neurourol Urodyn. 2014;33:39-45. [PMID: 23775873 DOI: 10.1002/nau.22438] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
56 Reyes-mendez ME, Castro-sánchez LA, Dagnino-acosta A, Aguilar-martínez I, Pérez-burgos A, Vázquez-jiménez C, Moreno-galindo EG, Álvarez-cervera FJ, Góngora-alfaro JL, Navarro-polanco RA, Alamilla J. Capsaicin produces antidepressant-like effects in the forced swimming test and enhances the response of a sub-effective dose of amitriptyline in rats. Physiology & Behavior 2018;195:158-66. [DOI: 10.1016/j.physbeh.2018.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
57 Nilius B. TRP channels in disease. Biochim Biophys Acta 2007;1772:805-12. [PMID: 17368864 DOI: 10.1016/j.bbadis.2007.02.002] [Cited by in Crossref: 204] [Cited by in F6Publishing: 202] [Article Influence: 13.6] [Reference Citation Analysis]
58 Shimizu T, Shibata M, Toriumi H, Iwashita T, Funakubo M, Sato H, Kuroi T, Ebine T, Koizumi K, Suzuki N. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A. Neurobiology of Disease 2012;48:367-78. [DOI: 10.1016/j.nbd.2012.07.010] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
59 Kym PR, Kort ME, Hutchins CW. Analgesic potential of TRPV1 antagonists. Biochemical Pharmacology 2009;78:211-6. [DOI: 10.1016/j.bcp.2009.02.014] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 6.4] [Reference Citation Analysis]
60 Evans MS, Cheng X, Jeffry JA, Disney KE, Premkumar LS. Sumatriptan inhibits TRPV1 channels in trigeminal neurons. Headache 2012;52:773-84. [PMID: 22289052 DOI: 10.1111/j.1526-4610.2011.02053.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
61 Takemura M, Quarcoo D, Niimi A, Dinh QT, Geppetti P, Fischer A, Chung KF, Groneberg DA. Is TRPV1 a useful target in respiratory diseases? Pulm Pharmacol Ther 2008;21:833-9. [PMID: 18992356 DOI: 10.1016/j.pupt.2008.09.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
62 Athanasopoulos A, Cruz F. The medical treatment of overactive bladder, including current and future treatments. Expert Opinion on Pharmacotherapy 2011;12:1041-55. [DOI: 10.1517/14656566.2011.554399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
63 Lumpkin EA, Caterina MJ. Mechanisms of sensory transduction in the skin. Nature 2007;445:858-65. [DOI: 10.1038/nature05662] [Cited by in Crossref: 469] [Cited by in F6Publishing: 423] [Article Influence: 31.3] [Reference Citation Analysis]
64 Yamamoto S, Wajima T, Hara Y, Nishida M, Mori Y. Transient receptor potential channels in Alzheimer's disease. Biochim Biophys Acta 2007;1772:958-67. [PMID: 17490865 DOI: 10.1016/j.bbadis.2007.03.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
65 Zhai K, Liskova A, Kubatka P, Büsselberg D. Calcium Entry through TRPV1: A Potential Target for the Regulation of Proliferation and Apoptosis in Cancerous and Healthy Cells. Int J Mol Sci 2020;21:E4177. [PMID: 32545311 DOI: 10.3390/ijms21114177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
66 Park SR, Kim J, Lee SY, Park YH, Kim HD. 2-Methylacrylamide as a bioisoster of thiourea group for 1,3-dibenzylthioureido TRPV1 receptor antagonists. Bioorg Med Chem Lett 2018;28:2080-3. [PMID: 29709253 DOI: 10.1016/j.bmcl.2018.04.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Nilius B, Szallasi A, Sibley DR. Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacol Rev 2014;66:676-814. [DOI: 10.1124/pr.113.008268] [Cited by in Crossref: 291] [Cited by in F6Publishing: 274] [Article Influence: 36.4] [Reference Citation Analysis]
68 van Veghel D, Cleynhens J, Pearce LV, DeAndrea-Lazarus IA, Blumberg PM, Van Laere K, Verbruggen A, Bormans G. New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation. ACS Chem Neurosci 2013;4:624-34. [PMID: 23421633 DOI: 10.1021/cn300233v] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
69 Iannone LF, De Logu F, Geppetti P, De Cesaris F. The role of TRP ion channels in migraine and headache. Neurosci Lett 2022;768:136380. [PMID: 34861342 DOI: 10.1016/j.neulet.2021.136380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
70 Thorat SA, Kang DW, Ryu H, Kim MS, Kim HS, Ann J, Ha T, Kim SE, Son K, Choi S, Blumberg PM, Frank R, Bahrenberg G, Schiene K, Christoph T, Lee J. 2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region. Eur J Med Chem 2013;64:589-602. [PMID: 23685943 DOI: 10.1016/j.ejmech.2013.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
71 Bíró T, Tóth BI, Marincsák R, Dobrosi N, Géczy T, Paus R. TRP channels as novel players in the pathogenesis and therapy of itch. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2007;1772:1004-21. [DOI: 10.1016/j.bbadis.2007.03.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
72 Zhang H, Inoue R, Shi J, Jin XH, Li YQ. Synergistic actions of diacylglycerol and inositol 1,4,5 trisphosphate for Ca2+-dependent inactivation of TRPC7 channel. Acta Pharmacol Sin 2008;29:90-7. [PMID: 18158870 DOI: 10.1111/j.1745-7254.2008.00721.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
73 Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci 2011;56:3288-95. [PMID: 21573941 DOI: 10.1007/s10620-011-1740-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
74 Charrua A, Cruz CD, Narayanan S, Gharat L, Gullapalli S, Cruz F, Avelino A. GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models. Journal of Urology 2009;181:379-86. [DOI: 10.1016/j.juro.2008.08.121] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
75 Neubert JK, Mannes AJ, Karai LJ, Jenkins AC, Zawatski L, Abu-Asab M, Iadarola MJ. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain 2008;4:3. [PMID: 18199335 DOI: 10.1186/1744-8069-4-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
76 Li M, Sun Y, Simard JM, Chai TC. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol Urodyn 2011;30:606-11. [PMID: 21351130 DOI: 10.1002/nau.21045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
77 Perner RJ, Koenig JR, Didomenico S, Gomtsyan A, Schmidt RG, Lee C, Hsu MC, Mcdonald HA, Gauvin DM, Joshi S, Turner TM, Reilly RM, Kym PR, Kort ME. Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists. Bioorganic & Medicinal Chemistry 2010;18:4821-9. [DOI: 10.1016/j.bmc.2010.04.099] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
78 Friedland K, Harteneck C. Spices and Odorants as TRP Channel Activators. In: Buettner A, editor. Springer Handbook of Odor. Cham: Springer International Publishing; 2017. pp. 85-6. [DOI: 10.1007/978-3-319-26932-0_34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Othman AA, Nothaft W, Awni WM, Dutta S. Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials. J Clin Pharmacol 2012;52:1028-41. [PMID: 21566201 DOI: 10.1177/0091270011407497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
80 Auzanneau C, Norez C, Antigny F, Thoreau V, Jougla C, Cantereau A, Becq F, Vandebrouck C. Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel. Biochem Pharmacol 2008;75:476-83. [PMID: 17945192 DOI: 10.1016/j.bcp.2007.09.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
81 Castro-Junior CJ, Milano J, Souza AH, Silva JF, Rigo FK, Dalmolin G, Cordeiro MN, Richardson M, Barros AG, Gomez RS, Silva MA, Kushmerick C, Ferreira J, Gomez MV. Phα1β toxin prevents capsaicin-induced nociceptive behavior and mechanical hypersensitivity without acting on TRPV1 channels. Neuropharmacology 2013;71:237-46. [PMID: 23597507 DOI: 10.1016/j.neuropharm.2013.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
82 Rainero I, Rubino E, Paemeleire K, Gai A, Vacca A, De Martino P, Gentile S, Sarchielli P, Pinessi L. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain 2013;14:61. [PMID: 23848401 DOI: 10.1186/1129-2377-14-61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
83 Kunde DA, Crawford A, Geraghty DP. Tachykinin (NK1, NK2 and NK3) receptor, transient receptor potential vanilloid 1 (TRPV1) and early transcription factor, cFOS, mRNA expression in rat tissues following systemic capsaicin treatment. Regul Pept 2013;183:35-41. [PMID: 23499799 DOI: 10.1016/j.regpep.2013.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
84 Alawi K, Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2010;125:181-95. [PMID: 19896501 DOI: 10.1016/j.pharmthera.2009.10.005] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 7.8] [Reference Citation Analysis]
85 Liu MG, Zhuo M. No requirement of TRPV1 in long-term potentiation or long-term depression in the anterior cingulate cortex. Mol Brain 2014;7:27. [PMID: 24708859 DOI: 10.1186/1756-6606-7-27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
86 Whiting S, Derbyshire E, Tiwari B. Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data. Appetite 2014;73:183-8. [DOI: 10.1016/j.appet.2013.11.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
87 Birder LA. TRPs in bladder diseases. Biochim Biophys Acta 2007;1772:879-84. [PMID: 17560087 DOI: 10.1016/j.bbadis.2007.04.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
88 Novakova-tousova K, Vyklicky L, Susankova K, Benedikt J, Samad A, Teisinger J, Vlachova V. Functional changes in the vanilloid receptor subtype 1 channel during and after acute desensitization. Neuroscience 2007;149:144-54. [DOI: 10.1016/j.neuroscience.2007.07.039] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
89 Vriens J, Appendino G, Nilius B. Pharmacology of Vanilloid Transient Receptor Potential Cation Channels. Mol Pharmacol 2009;75:1262-79. [DOI: 10.1124/mol.109.055624] [Cited by in Crossref: 286] [Cited by in F6Publishing: 269] [Article Influence: 22.0] [Reference Citation Analysis]
90 Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008;29:550-7. [PMID: 18805596 DOI: 10.1016/j.tips.2008.08.003] [Cited by in Crossref: 130] [Cited by in F6Publishing: 127] [Article Influence: 9.3] [Reference Citation Analysis]
91 Gomtsyan A, Bayburt EK, Keddy R, Turner SC, Jinkerson TK, Didomenico S, Perner RJ, Koenig JR, Drizin I, Mcdonald HA, Surowy CS, Honore P, Mikusa J, Marsh KC, Wetter JM, Faltynek CR, Lee C. α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model. Bioorganic & Medicinal Chemistry Letters 2007;17:3894-9. [DOI: 10.1016/j.bmcl.2007.04.105] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
92 Aguilar-Martinez IS, Reyes-Mendez ME, Herrera-Zamora JM, Osuna-Lopez F, Virgen-Ortiz A, Mendoza-Munoz N, Gongora-Alfaro JL, Moreno-Galindo EG, Alamilla J. Synergistic antidepressant-like effect of capsaicin and citalopram reduces the side effects of citalopram on anxiety and working memory in rats. Psychopharmacology (Berl) 2020;237:2173-85. [PMID: 32388621 DOI: 10.1007/s00213-020-05528-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Planells-Cases1 R, Ferrer-Montiel A. Drug design and development through the vanilloid receptor. Expert Opin Drug Discov 2007;2:1053-63. [PMID: 23484872 DOI: 10.1517/17460441.2.8.1053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
94 Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev. 2014;94:265-301. [PMID: 24382888 DOI: 10.1152/physrev.00031.2013] [Cited by in Crossref: 296] [Cited by in F6Publishing: 266] [Article Influence: 37.0] [Reference Citation Analysis]
95 Thomas KC, Sabnis AS, Johansen ME, Lanza DL, Moos PJ, Yost GS, Reilly CA. Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells. J Pharmacol Exp Ther 2007;321:830-8. [PMID: 17332266 DOI: 10.1124/jpet.107.119412] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
96 Jara-Oseguera A, Simon SA, Rosenbaum T. TRPV1: on the road to pain relief. Curr Mol Pharmacol 2008;1:255-69. [PMID: 20021438 DOI: 10.2174/1874467210801030255] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
97 Tsuji F, Murai M, Oki K, Seki I, Ueda K, Inoue H, Nagelkerken L, Sasano M, Aono H. Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents. Eur J Pharmacol 2010;627:332-9. [PMID: 19878665 DOI: 10.1016/j.ejphar.2009.10.044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
98 Nguyen TL, Nam YS, Lee SY, Kim HC, Jang CG. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice. Br J Anaesth 2010;105:668-74. [PMID: 20719804 DOI: 10.1093/bja/aeq212] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
99 Morita S, Miyata S. Different vascular permeability between the sensory and secretory circumventricular organs of adult mouse brain. Cell Tissue Res 2012;349:589-603. [PMID: 22584508 DOI: 10.1007/s00441-012-1421-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 6.5] [Reference Citation Analysis]
100 Duan L, Yan Y, Sun Y, Zhao B, Hu W, Li G. Contribution of TRPV1 and multidrug resistance proteins in the permeation of capsaicin across different intestinal regions. Int J Pharm 2013;445:134-40. [PMID: 23402980 DOI: 10.1016/j.ijpharm.2013.02.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
101 Ryu H, Seo S, Cho SH, Kim HS, Jung A, Kang DW, Son K, Cui M, Hong SH, Sharma PK, Choi S, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Stockhausen H, Schiene K, Christoph T, Frormann S, Lee J. 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists. Bioorg Med Chem Lett 2014;24:4039-43. [PMID: 24948568 DOI: 10.1016/j.bmcl.2014.05.074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
102 Feng Z, Pearce LV, Zhang Y, Xing C, Herold BK, Ma S, Hu Z, Turcios NA, Yang P, Tong Q, McCall AK, Blumberg PM, Xie XQ. Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation. AAPS J 2016;18:898-913. [PMID: 27000851 DOI: 10.1208/s12248-016-9888-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
103 Santos-Silva A, Charrua A, Cruz CD, Gharat L, Avelino A, Cruz F. Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Auton Neurosci 2012;166:35-8. [PMID: 22037502 DOI: 10.1016/j.autneu.2011.09.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
104 Sun W, Liu K, Ryu H, Kang DW, Kim YS, Kim MS, Cho Y, Bhondwe RS, Thorat SA, Kim HS, Pearce LV, Pavlyukovets VA, Tran R, Morgan MA, Lazar J, Ryder CB, Toth A, Blumberg PM, Lee J. 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions. Bioorg Med Chem 2012;20:1310-8. [PMID: 22227463 DOI: 10.1016/j.bmc.2011.12.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Maher MP, Bhattacharya A, Ao H, Swanson N, Wu NT, Freedman J, Kansagara M, Scott B, Li DH, Eckert WA 3rd, Liu Y, Sepassi K, Rizzolio M, Fitzgerald A, Liu J, Branstetter BJ, Rech JC, Lebsack AD, Breitenbucher JG, Wickenden AD, Chaplan SR. Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist. Eur J Pharmacol 2011;663:40-50. [PMID: 21575625 DOI: 10.1016/j.ejphar.2011.05.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
106 Wirkner K, Stanchev D, Milius D, Hartmann L, Kato E, Zadori ZS, Mager PP, Rubini P, Nörenberg W, Illes P. Regulation of the pH sensitivity of human P2X receptors by N-linked glycosylation. J Neurochem 2008;107:1216-24. [PMID: 18778308 DOI: 10.1111/j.1471-4159.2008.05655.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
107 van Veghel D, Cleynhens J, Pearce LV, Blumberg PM, Van Laere K, Verbruggen A, Bormans G. Synthesis and biological evaluation of [¹¹C]SB366791: a new PET-radioligand for in vivo imaging of the TRPV1 receptor. Nucl Med Biol 2013;40:141-7. [PMID: 23141549 DOI: 10.1016/j.nucmedbio.2012.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
108 Luo D, Zhang YW, Peng WJ, Peng J, Chen QQ, Li D, Deng HW, Li YJ. Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept 2008;150:66-72. [PMID: 18584893 DOI: 10.1016/j.regpep.2008.05.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
109 Lehmann R, Schöbel N, Hatt H, van Thriel C. The involvement of TRP channels in sensory irritation: a mechanistic approach toward a better understanding of the biological effects of local irritants. Arch Toxicol 2016;90:1399-413. [PMID: 27037703 DOI: 10.1007/s00204-016-1703-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
110 Lam PMW, Hainsworth AH, Smith GD, Owen DE, Davies J, Lambert DG. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca2+]i, initiates neurotransmitter release and promotes delayed cell death: Heterologous expression of TRPV1 in neuronal cells. Journal of Neurochemistry 2007;102:801-11. [DOI: 10.1111/j.1471-4159.2007.04569.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
111 Bourinet E, Altier C, Hildebrand ME, Trang T, Salter MW, Zamponi GW. Calcium-permeable ion channels in pain signaling. Physiol Rev 2014;94:81-140. [PMID: 24382884 DOI: 10.1152/physrev.00023.2013] [Cited by in Crossref: 162] [Cited by in F6Publishing: 145] [Article Influence: 20.3] [Reference Citation Analysis]
112 Rosenbaum T, Morales-Lázaro SL, Islas LD. TRP channels: a journey towards a molecular understanding of pain. Nat Rev Neurosci 2022. [PMID: 35831443 DOI: 10.1038/s41583-022-00611-7] [Reference Citation Analysis]
113 Sato H, Castrillon E, Cairns B, Bendixen K, Wang K, Nakagawa T, Wajima K, Svensson P. Intramuscular pH modulates glutamate-evoked masseter muscle pain magnitude in humans. Eur J Pain 2016;20:106-15. [DOI: 10.1002/ejp.697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
114 Rossi F, Siniscalco D, Luongo L, De Petrocellis L, Bellini G, Petrosino S, Torella M, Santoro C, Nobili B, Perrotta S, Di Marzo V, Maione S. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 2009;44:476-84. [PMID: 19059369 DOI: 10.1016/j.bone.2008.10.056] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
115 Birder LA. Urothelial signaling. Auton Neurosci. 2010;153:33-40. [PMID: 19666243 DOI: 10.1016/j.autneu.2009.07.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
116 Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6:357-72. [DOI: 10.1038/nrd2280] [Cited by in Crossref: 548] [Cited by in F6Publishing: 510] [Article Influence: 36.5] [Reference Citation Analysis]
117 Breivik T, Gundersen Y, Gjermo P, Fristad I, Opstad PK. Systemic chemical desensitization of peptidergic sensory neurons with resiniferatoxin inhibits experimental periodontitis. Open Dent J 2011;5:1-6. [PMID: 21339860 DOI: 10.2174/1874210601105010001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
118 Bosland PW. Hot stuff - do people living in hot climates like their food spicy hot or not? Temperature (Austin) 2016;3:41-2. [PMID: 27227093 DOI: 10.1080/23328940.2015.1130521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Mannari T, Morita S, Furube E, Tominaga M, Miyata S. Astrocytic TRPV1 ion channels detect blood-borne signals in the sensory circumventricular organs of adult mouse brains. Glia 2013;61:957-71. [PMID: 23468425 DOI: 10.1002/glia.22488] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
120 Fernández-garcía E, Pérez-gálvez A. Flavoring Compounds in Red Pepper Fruits (Capsicum genus) and Processed Products. In: Hui YH, editor. Handbook of Fruit and Vegetable Flavors. Hoboken: John Wiley & Sons, Inc.; 2010. pp. 909-34. [DOI: 10.1002/9780470622834.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Bongsebandhu-phubhakdi S, Phisonkulkasem T, Srikiatkhachorn A. Nociceptin/Orphanin FQ Modulates Cortical Activity and Trigeminal Nociception. Headache: The Journal of Head and Face Pain 2011;51:1245-53. [DOI: 10.1111/j.1526-4610.2011.01958.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
122 Lambert DG. Capsaicin receptor antagonists: a promising new addition to the pain clinic. Br J Anaesth 2009;102:153-5. [PMID: 19151045 DOI: 10.1093/bja/aen354] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
123 Birder LA. Urothelial Signaling. In: Andersson K, Michel MC, editors. Urinary Tract. Berlin: Springer Berlin Heidelberg; 2011. pp. 207-31. [DOI: 10.1007/978-3-642-16499-6_10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
124 Jetter MC, McNally JJ, Youngman MA, McDonnell ME, Dubin AE, Nasser N, Zhang SP, Codd EE, Colburn RW, Stone DR, Brandt MR, Flores CM, Dax SL. N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1). Bioorg Med Chem Lett 2008;18:2730-4. [PMID: 18359227 DOI: 10.1016/j.bmcl.2008.02.075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
125 Medvedeva YV, Kim MS, Usachev YM. Mechanisms of prolonged presynaptic Ca2+ signaling and glutamate release induced by TRPV1 activation in rat sensory neurons. J Neurosci 2008;28:5295-311. [PMID: 18480286 DOI: 10.1523/JNEUROSCI.4810-07.2008] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
126 Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, de Novellis V, Di Marzo V. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 2007;27:13739-49. [PMID: 18077685 DOI: 10.1523/JNEUROSCI.3258-07.2007] [Cited by in Crossref: 123] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
127 Sándor K, Helyes Z, Gyires K, Szolcsányi J, László J. Static magnetic field-induced anti-nociceptive effect and the involvement of capsaicin-sensitive sensory nerves in this mechanism. Life Sci 2007;81:97-102. [PMID: 17568617 DOI: 10.1016/j.lfs.2007.04.029] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
128 Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn 2007;26:920-7. [PMID: 17705161 DOI: 10.1002/nau.20479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
129 Frias B, Charrua A, Avelino A, Michel MC, Cruz F, Cruz CD. Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input: TRPV1 MEDIATES NGF-INDUCED BLADDER HYPERACTIVITY. BJU International 2012;110:E422-8. [DOI: 10.1111/j.1464-410x.2012.11187.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
130 Mizrak SC, Gadella BM, Erdost H, Ozer A, van Pelt AM, van Dissel-Emiliani FM. Spermatogonial stem cell sensitivity to capsaicin: an in vitro study. Reprod Biol Endocrinol 2008;6:52. [PMID: 19014578 DOI: 10.1186/1477-7827-6-52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]